Most common (>25%) TEAEs
| . | Daratumumab plus pom-dex (N = 103) . | |
|---|---|---|
| Any grade . | Grade 3/4 . | |
| Total AEs | 103 (100) | 102 (99) |
| Neutropenia | 82 (80) | 79 (77) |
| Anemia | 56 (54) | 29 (28) |
| Fatigue | 54 (52) | 12 (12) |
| Diarrhea | 44 (43) | 4 (4) |
| Thrombocytopenia | 43 (42) | 20 (19) |
| Cough | 39 (38) | 1* (1) |
| Leukopenia | 38 (37) | 25 (24) |
| Constipation | 35 (34) | 0 (0) |
| Dyspnea | 33 (32) | 8 (8) |
| Nausea | 32 (31) | 0 (0) |
| Pyrexia | 31 (30) | 2 (2) |
| Back pain | 29 (28) | 6 (6) |
| Upper respiratory tract infection | 29 (28) | 3 (3) |
| Muscle spasms | 28 (27) | 1 (1) |
| . | Daratumumab plus pom-dex (N = 103) . | |
|---|---|---|
| Any grade . | Grade 3/4 . | |
| Total AEs | 103 (100) | 102 (99) |
| Neutropenia | 82 (80) | 79 (77) |
| Anemia | 56 (54) | 29 (28) |
| Fatigue | 54 (52) | 12 (12) |
| Diarrhea | 44 (43) | 4 (4) |
| Thrombocytopenia | 43 (42) | 20 (19) |
| Cough | 39 (38) | 1* (1) |
| Leukopenia | 38 (37) | 25 (24) |
| Constipation | 35 (34) | 0 (0) |
| Dyspnea | 33 (32) | 8 (8) |
| Nausea | 32 (31) | 0 (0) |
| Pyrexia | 31 (30) | 2 (2) |
| Back pain | 29 (28) | 6 (6) |
| Upper respiratory tract infection | 29 (28) | 3 (3) |
| Muscle spasms | 28 (27) | 1 (1) |
Values represent n (%) of patients.
Reported as “productive cough.”